Meeting
2022 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns, survival outcomes, and health care resource utilization among individuals with nonmuscle-invasive bladder cancer in Canada.
Authors
Tamer N. Jarada
University of Calgary, Calgary, AB, Canada
Tamer N. Jarada , Geoffrey Gotto , Bimal Bhindi , Natalie Beaton , Tahir Feroz , Teagan Maier-Downing , Darren Brenner , Winson Y. Cheung , Devon J. Boyne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 470)
DOI
10.1200/JCO.2022.40.6_suppl.470
Abstract #
470
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.
First Author: Javier Puente
Poster
2022 ASCO Quality Care Symposium
Real-world treatment (tx) patterns, cost, and overall survival (OS) by line of therapy among patients (pt) with mantle cell lymphoma (MCL): A SEER-Medicare (SM) analysis.
First Author: Scott J. Keating
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term follow-up of intravesical gemcitabine and docetaxel as rescue therapy for nonmuscle-invasive bladder cancer.
First Author: Phani T. Chevuru
Poster
2017 ASCO Quality Care Symposium
The use of real-world data to examine comparative effectiveness research (CER) and treatment patterns in HER2-negative and triple-negative metastatic breast cancer (MBC): A systematic literature review.
First Author: Monika Parisi